Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kathy Hibbs, Nelson Chan

Premium

Kathy Hibbs is 23andMe's new chief legal and regulatory officer.

Hibbs joins 23andMe from Genomic Health, where she served as senior vice president and general counsel. She has also worked at Monogram Biosciences and Varian Medical Systems, and is actively engaged in a number of industry groups, such as the American Clinical Laboratory Association, the Coalition for 21st Century Medicine, and the Personalized Medicine Coalition.

Hibbs joins 23andMe while the firm is in the midst of regulatory discussions with the US Food and Drug Administration regarding its Personal Genome Service. Last November, 23andMe received a warning letter in which the agency asked the personal genomics company to stop marketing health-related information to customers without its clearance. While the regulatory issues are being ironed out, 23andMe continues to provide new customers their raw, uninterpreted genomic data and ancestry-related reports.


Nelson Chan has been appointed to the board of Jade Sky Technologies, an LED driver manufacturer.

Chain is a director of Affymetrix, Synaptics, and Bridgelux, and is chairman of the board of Outerwall. He is also a former CEO of Magellan.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.